NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
Position in CHRS — Coherus Oncology, Inc.
CIK 921739
PHILADELPHIA, PA
Position in CHRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,520,998
+$243,000 QoQ
Shares Held
899,999
0.0% QoQ
Ownership
0.583%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NOMURA ASSET MANAGEMENT INTERNATIONAL INC. holds $1,730,739,780 across 77 Biotechnology names. CHRS ranks #58 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
1,143,739 | $187,024,201 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
812,809 | $137,380,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
556,427 | $127,271,547 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
573,312 | $114,461,740 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
1,534,736 | $113,969,495 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
3,270,513 | $97,166,941 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,726,907 | $90,248,159 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
258,905 | $85,663,897 |
All Filings in CHRS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,520,998 | 899,999 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,277,998 | 899,999 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||